Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Maitland has served as a consultant and/or on advisory boards for Encysive Pharmaceuticals Inc., Gilead Sciences Inc., Pfizer Inc., and United Therapeutics. Dr. Shah has received research grant support from Actelion Pharmaceuticals Ltd. (Entelligence Young Investigator Award) and is also the recipient of a Scientist Development Grant from the American Heart Association, Dallas, Texas.
Authors:
- Amit K. MehrotraAMAmit K. Mehrotra
- Thenappan ThenappanTTThenappan Thenappan
- Mardi Gomberg-MaitlandMGMardi Gomberg-Maitland
- Sanjiv J. ShahSSSanjiv J. Shah
- 1 September 2009
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 104 (6) , 868-872
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiographyInternational Journal of Cardiology, 2010
- Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary DiseaseCirculation, 2008
- A USA-based registry for pulmonary arterial hypertension: 1982–2006European Respiratory Journal, 2007
- Red Cell Distribution Width as a Novel Prognostic Marker in Heart FailureJACC, 2007
- Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary HypertensionChest, 2006
- The Seattle Heart Failure ModelCirculation, 2006
- Predictors of mortality and morbidity in patients with chronic heart failureEuropean Heart Journal, 2005
- Anemia as a risk factor and therapeutic target in heart failureJACC, 2004
- Prognosis of Pulmonary Arterial Hypertension*Chest, 2004
- Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failureThe American Journal of Cardiology, 2003